1. Home
  2. VSAT vs EVO Comparison

VSAT vs EVO Comparison

Compare VSAT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSAT
  • EVO
  • Stock Information
  • Founded
  • VSAT 1986
  • EVO 1993
  • Country
  • VSAT United States
  • EVO Germany
  • Employees
  • VSAT N/A
  • EVO N/A
  • Industry
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSAT Technology
  • EVO Health Care
  • Exchange
  • VSAT Nasdaq
  • EVO Nasdaq
  • Market Cap
  • VSAT 1.9B
  • EVO 1.5B
  • IPO Year
  • VSAT 1996
  • EVO 2021
  • Fundamental
  • Price
  • VSAT $14.60
  • EVO $4.07
  • Analyst Decision
  • VSAT Buy
  • EVO Buy
  • Analyst Count
  • VSAT 7
  • EVO 2
  • Target Price
  • VSAT $20.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • VSAT 3.5M
  • EVO 112.1K
  • Earning Date
  • VSAT 08-06-2025
  • EVO 08-13-2025
  • Dividend Yield
  • VSAT N/A
  • EVO N/A
  • EPS Growth
  • VSAT N/A
  • EVO N/A
  • EPS
  • VSAT N/A
  • EVO N/A
  • Revenue
  • VSAT $4,519,571,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • VSAT $4.46
  • EVO $10.08
  • Revenue Next Year
  • VSAT $3.58
  • EVO $10.99
  • P/E Ratio
  • VSAT N/A
  • EVO N/A
  • Revenue Growth
  • VSAT 5.50
  • EVO 1.50
  • 52 Week Low
  • VSAT $6.69
  • EVO $2.84
  • 52 Week High
  • VSAT $26.70
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • VSAT 60.99
  • EVO 47.66
  • Support Level
  • VSAT $14.31
  • EVO $4.12
  • Resistance Level
  • VSAT $16.20
  • EVO $4.26
  • Average True Range (ATR)
  • VSAT 0.78
  • EVO 0.11
  • MACD
  • VSAT -0.05
  • EVO -0.01
  • Stochastic Oscillator
  • VSAT 53.27
  • EVO 54.84

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: